Hollywood Bowl Group (LON:BOWL – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Berenberg Bank in a note issued to investors on Tuesday, Marketbeat Ratings reports. They currently have a GBX 450 price target on the stock. Berenberg Bank’s price target would indicate a potential upside of 82.56% from the stock’s current price.
Other equities research analysts have also issued research reports about the stock. Shore Capital Group restated a “buy” rating and issued a GBX 350 target price on shares of Hollywood Bowl Group in a report on Friday, July 10th. Royal Bank Of Canada cut their price target on shares of Hollywood Bowl Group from GBX 420 to GBX 415 and set an “outperform” rating on the stock in a report on Monday, June 1st. Four equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has an average rating of “Buy” and an average target price of GBX 397.75.
Read Our Latest Report on BOWL
Hollywood Bowl Group Stock Up 0.2%
Hollywood Bowl Group declared that its board has approved a share buyback program on Wednesday, July 1st that authorizes the company to repurchase 0 outstanding shares. This repurchase authorization authorizes the company to purchase shares of its stock through open market purchases. Stock repurchase programs are usually an indication that the company’s management believes its stock is undervalued.
About Hollywood Bowl Group
Hollywood Bowl Group plc is a leading international leisure operator of ten-pin bowling and mini-golf centres, bringing families and friends together for affordable fun and safe, healthy competition.
Our unique purpose-led culture and proven investment-led strategy are enabling us to capitalise on the significant growth opportunities in the markets we operate in, and achieve strong returns on capital invested.
We are market leader in the UK and Canada, and one of the largest operators of ten-pin bowling centres in the world.
Featured Articles
- Five stocks we like better than Hollywood Bowl Group
- Why Concentra’s Quiet Healthcare Business Keeps Winning
- Inhibrx’s Insider Buying Adds Fuel to a High-Short-Interest Biotech Setup
- Alamos Gold’s 1 Million-Ounce Growth Story Is Hiding in Plain Sight
- Everyone in AI Is Quietly Copying Palantir’s Playbook
Receive News & Ratings for Hollywood Bowl Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hollywood Bowl Group and related companies with MarketBeat.com's FREE daily email newsletter.
